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Abstract
Background: To evaluate whether the introduction of a strict protocol based on the systemic
evaluation of critically ill pregnant women with complications of hypertension affected the outcome
of those women.
Method: Study group: Indigent South African women managed in the tertiary hospitals of the
Pretoria Academic Complex. Since 1997 a standard definition of women with severe acute
maternal morbidity (SAMM), also referred to as a Nearmiss, has been used in the Pretoria
Academic Complex. All cases of SAMM and maternal deaths (MD) were entered on the Maternal
Morbidity and Mortality Audit System programme (MaMMAS). A comparison of outcome of
severely ill women who had complications of hypertension in pregnancy was performed between
1997–1998 (original protocol) and 2002–2003 (strict protocol). Data include women referred from
outside the Pretoria Academic Complex area to the tertiary hospitals.
Results: Between 1997–1998 there were 79 women with SAMM and 18 maternal deaths due to
complications of hypertension, compared with 91 women with SAMM and 13 maternal deaths in
2002–2003. The mortality index (MI) declined from 18.6% to 12.5% (OR 0.62, 95% CI 0.27–1.45).
Statistically significant fewer women had renal failure (RR 0.37, 95% CI 0.21 – 0.66) and cerebral
complications (RR 0.52, 95%CI 0.34 – 0.81) during the second period, and liver dysfunction (RR
0.27 95%CI 0.06 – 1.25) tended to be lower. However, there tended to be an increase in the
number of women, who had immune system failure (RR 4.2 95%CI 0.93 – 18.94) and respiratory
failure (RR 1.42 95%CI 0.88 – 2.29) although it did not reach significance. Cardiac failure remained
constant (RR 0.84 95%CI 0.54 – 1.30).
Conclusion:  The strict protocol approach based on the systemic evaluation of severely ill
pregnant women with complications of hypertension and an intensive, regular feedback mechanism
has been associated with a reduction in the number of patients with renal failure and cerebral
compromise.
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Background
Complications due to hypertensive disease in pregnancy
are the most common direct cause of maternal death
(MD) in South Africa [1,2]. They are also the most com-
mon cause of acute severe morbidity in a survey of three
clearly defined geographical areas in South Africa [3]. The
final and contributory causes of deaths were most com-
monly cerebral complications (40% and 50%), cardiac
failure (40% and 35%), respiratory failure (15% and
16%) and renal failure (10% and 18%) in 1998 and
1999–2001 respectively [1,2]. Any strategy for improving
the outcome of severely ill pregnant women with compli-
cations due to hypertension would have to address ways
of preventing these organ systems from failing.
In 1997, the Pretoria Academic Complex initiated the use
of a standard definition of severe acute maternal morbid-
ity (SAMM) [4] and the routine collection of data since.
Table 1 shows the definition for organ system dysfunction
for each specific organ system. After the initial survey in
1997–1998, protocols were reviewed and a new approach
to managing severely ill pregnant women was introduced.
This system was based on the systematic routine evalua-
tion of all organ systems and, where an abnormality was
detected, this served as a trigger to further investigate and
support that organ system [5]. This policy was adopted for
managing critically ill pregnant women with specific com-
mon conditions and as a group became known as "the
strict protocols".
The implementation of new policies can be difficult to
achieve [6]. The change in policy was effected by regular
reinforcement at daily audit meetings at the individual
hospitals and weekly departmental meetings where all
cases of SAMM and MD were discussed. New trainees were
introduced to the protocols from the start, face-to-face
meetings were held when problems were detected, and
special training sessions were introduced to stress specific
points. Finally, a report was compiled and presented to
the provincial administration with specific recommenda-
tions appropriate to the region. There has been ongoing
regular contact since then.
This study examines the effect of the introduction of this
strict protocol on the outcome of critically ill pregnant
women with complications of hypertension in pregnancy
and attempts to identify where further research or change
in policy is required.
Methods
The Pretoria Academic Complex consists of two academic
hospitals (Pretoria Academic and Kalafong) and two dis-
trict hospitals (Mamelodi Day and Pretoria West). The
area receives referrals from other areas within Gauteng
Province and the surrounding provinces. The Pretoria Aca-
demic Complex serves a population of 3 million people.
The population served is mainly an indigent general
South African population. The female population was 554
000 in 1996 with an annual growth of 10%, the fertility
rate for Gauteng is 2.3% for women aged 15 to 49 and the
current pregnancy rate is 2.2% [17]. The number of births
within the immediate area has increased by twenty per-
cent over the last five years and is currently approximately
15 000 per year. For the period of 1997/1998, the total
number of births was 27 025, the maternal mortality ratio
was 133.2/100 000 births and the perinatal mortality rate
was 37/1000 for babies weighing more than 1000 gr. For
the period of 2002/2003 the total number of births was
32 814, the maternal mortality ratio was 115.8/100 000
births and the perinatal mortality rate for babies weighing
more than 1000 gr was 27/1000 births.
The criteria for SAMM have been defined by Mantel et al.
[4] as a woman with organ system dysfunction or failure
who would probably have died if un- or inadequately
treated. The criteria are based on clinical evaluation with
limited specific investigations that are readily available at
all regional, secondary and higher level hospitals.
Data on women with SAMM and MD were collected every
morning at the respective hospitals and a near miss form
was completed for each woman with SAMM and the
maternal death notification form for all maternal deaths.
The data were entered into the Maternal Morbidity and
Mortality Audit System (MaMMAS) database, developed
by Johan Coetzee (Simply Software). Data from 1997/
1998 (initial project) [3] served as the platform for devel-
oping the database. This initial project compared Mater-
nal Mortality and Nearmiss to determine if disease pattern
was the same. In the second time period (2002/2003) the
strict protocol had been implemented and became
established.
Standard statistical techniques were used to compare the
two time periods. The chi square test was used to compare
categorical data. The outcome measures were the Mortal-
ity Index, defined as the number of maternal deaths
divided by the sum of women with SAMM and maternal
deaths, expressed as a percentage [7]. The criteria for each
organ system dysfunction/failure were specified in the
definition of a woman with SAMM [4] and the rates of
each organ system dysfunction were compared between
the two time periods. The relative risk was used to com-
pare the two time periods as it gives a more realistic indi-
cation of the changes.
During the first time period (1997/1998) there was no
strict protocol available and standard care was provided.
This consisted of magnesium sulphate for eclamptic fits
and hydralazine 1,25 mg ivi every 15 min for the acuteReproductive Health 2005, 2:7 http://www.reproductive-health-journal.com/content/2/1/7
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treatment of hypertension if the diastolic BP was ≥ 110
mmHg. A fluid balance chart was not routinely kept and
the management of the patient was mainly based on the
opinion of the attending consultant.
In contrast, the strict management protocol, implemented
during the second time period (2002/2003) included the
following:
Stabilization
The stabilization of the patient is summarised in Table 2.
Systemic Evaluation
Table 3 summarizes the systemic evaluation of the
mother.
Foetal Evaluation
An ultrasonographic evaluation of the foetus was per-
formed, once the mother had been stabilised, and
included the following:
• Estimated foetal weight
• Doppler of the umbilical artery
• Amniotic fluid index
Table 1: The criteria for a near-miss case for each specific organ system according to Mantel.
Organ system-based Markers
Cardiac dysfunction Pulmonary oedema
Cardiac arrest
Vascular dysfunction Hypovolaemia requiring ≥ 5 units of blood products
Immunological dysfunction ICU admission for sepsis
Emergency hysterectomy for sepsis
Respiratory dysfunction Intubation and ventilation for any reason other than general anaesthesia
Oxygen saturation of less than 90% for more than 60 min
The ratio of the partial pressure of oxygen in arterial blood to the percentage oxygen in inspired air is ≤ 3 (paO2/
FiO2 ≤ 3)
Renal dysfunction Oliguria, ≤ 400 ml/24 hr that does not respond to careful fluid replacement or attempts at inducing with dopamine 
or infusion
Acute deterioration in urea > 15 mmol/l or of creatinine to > 400 mmol/l
Liver dysfunction Jaundice in the presence of pre-eclampsia
Metabolic dysfunction Diabetic keto-acidosis
Coagulation dysfunction Acute thrombocytopenia requiring a platelet transfusion
Cerebral dysfunction Coma lasting > 12 hours
Subarachnoid or intracerebral haemorrhage
Table 2: Summary of stabilising the severely ill women with complications of Hypertension after admission to a High Care Obstetrics 
unit
Organ system Acute management Maintenance Management of complications
Fluid management Start IV line give 300 ml fluid bolus: 
100 ml Ringers lactate
200 ml normal saline with loading 
dose of magnesium sulphate Urinary 
Catheter
Give Ringers lactate 125 ml/hr iv.
Start a fluid balance chart
If poor output repeat fluid bolus. If 
still poor output and positive fluid 
balance start low-dose dopamine 
infusion
Magnesium Sulphate 4 g magnesium sulphate in 200 ml 
saline over 20 min iv
5 g magnesium sulphate with 1 ml 
lignocaine im in each buttock
Maintenance: 5 g four hourly iv
Check before next dosage: Urine 
output > 30 ml/hr
Tendon reflexes present
Respiratory rate more than 16/min
In case of magnesium sulphate 
overdose give calcium gluconate
Blood pressure control Repeat blood pressure after 20 min 
and if diastolic ≥ 110 or systolic ≥ 160 
treat according to the 
antihypertensive drug protocol
Use either nifedipine or labetolol
Neurological status If still confused check saturation and 
blood pressure
Abnormal saturation: Give oxygen via 
mask
Abnormal blood pressure: treat with 
appropriate drugs
If both are normal: give haloperidolReproductive Health 2005, 2:7 http://www.reproductive-health-journal.com/content/2/1/7
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• Transcerebellar diameter
• Middle cerebral artery Doppler
• Ductus venosus waveform
• Detection of possible structural abnormalities
If the expected foetal weight was more than 800 g or the
foetus was known to have a gestational age of 28 weeks or
more, the foetus was regarded as viable. In these cases cor-
ticosteroids were administered and the foetal heart rate
pattern was monitored six hourly with a cardiotocograph
(CTG).
After all this information had been gathered a manage-
ment plan was formulated. In most cases the laboratory
blood results (initially only aspartate-amino transferase
(AST), creatinine, haematocrit and platelets) were availa-
ble within the hour and during the stabilisation phase of
the patient. To make a final decision four questions
needed to be answered by the clinician, namely:
1. Is it safe for the mother to continue the pregnancy?
2. Is it safe for the foetus to continue the pregnancy?
3. What is the risk to neonate if the foetus was born?
4. What is the risk to the mother if the foetus was born?
In case of expectant management, the woman was trans-
ferred to a high care (high dependency unit) obstetric
unit, with daily evaluation by the registrar and routine
blood testing (haematocrit, platelets, creatinine and AST)
twice weekly. Cardiotocogram (CTG) (6 hourly) and
ultrasound (two-weekly) were used to assess foetal well-
being and growth. If there was concern about foetal
growth, ultrasound was repeated more often [10].
The indications for delivery were:
• Foetal distress
• Intra uterine death
• Expected birth weight more than 2 kg
• Expected birth weight less than 500 g
• Maternal organ system failure
• Uncontrollable hypertension
Table 3: Summary of the systemic evaluation and special investigations of critical ill women with complications of hypertension
Organ system evaluated Clinical examination Special investigations
Central nervous system Glasgow coma scale
Lateralising signs
Reflexes
Pupil reflexes
If any abnormalities consider CT Scan
Respiratory system Respiratory rate
Blood gas
Check for dullness on percussion, crepitations or wheezes
If any abnormalities do blood gas and Chest X-ray
Cardiovascular system: Pulse, Blood pressure
Heart sounds
Heart size
Radio-femoral delay
Gastro intestinal system: Check for epigastric tenderness, hepatomegaly Check AST and for jaundice. 4 hourly blood glucose test if 
raised AST
Renal system: Check for renal angle tenderness, macroscopic hematuria
Listen for murmurs over the renal artery
Check creatinine and fluid balance. If signs of kidney 
dysfunction do full kidney function tests
Haematological system: Check for anaemia, purpera, bleeding tendency Check hematocrit and platelets
Immune system: Body temperature
Check for generalized lymphadenopathy, splenomegaly, 
signs of immune system failure
Voluntary counselling and HIV testing if CD4 and ESR 
above 100
Musculosceletal System Check for signs of DVT
Check for spinal problems that might influence the type of 
anaesthesia
Gynaecological system: Abdominally: measure symphysis-fundus height, lie & 
position of the foetus, check for uterine tenderness or 
contractions, estimate foetal weight, measure amniotic 
fluid, check for foetal heart rate
Vaginal exam: assess the Bishop score
Fundoscopy: Check for silver wiring, papillar oedema and signs of 
bleedingReproductive Health 2005, 2:7 http://www.reproductive-health-journal.com/content/2/1/7
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• Eclampsia
• Proven foetal lung maturity
• Foetal abnormality
The indications for elective caesarean section were:
• Unfavourable Bishop score (4 or less)
• Foetal distress as diagnosed on the basis of spontaneous
decelerations on CTG
• Absent end diastolic flow of the uterine artery on
Doppler
• An abnormal ductus venosus waveform. The ductus ven-
osus wave form was regarded as abnormal if it was absent
or reversed.
Antihypertensive drug protocol
Alpha methyldopa was used as the first line oral antihy-
pertensive agent [10] (an initial dose of 500 mg 8 hourly
was used increasing to a maximum of 750 mg 8 hourly).
In cases of severe hypertension (blood pressure more than
160 mmHg systolic or 110 mmHg diastolic) 10 mg nifed-
ipine [11] was administered orally. Nifedipine (10 mg)
has replaced dihydralazine in the strict protocol as it is
more effective in controlling blood pressure and is safer
for the foetus [11,12]. If the blood pressure remained
higher than 160/110 mmHg after one hour a repeat dose
of nifedipine was given. If the woman was unable to swal-
low or had a tachycardia of more than 120 beats per
minute, labetolol [13] was administered: the patient was
started with 20 mg iv and if the blood pressure remained
above 160/110 mmHg after 10 min she would receive 40
mg iv. If her blood pressure still remained above 160/110
mmHg she would receive 80 mg iv. This would be
repeated another two times 10 minutes apart if needed.
Fluid management
After admission to the High Care Obstetric Unit, the
woman was maintained on 125 ml/hr Ringers lactate
intravenously. A strict input and output chart was
recorded by the nursing staff. The attending registrar
regularly determined the fluid balance taking into account
insensible and blood loss. If the patient was excreting less
than 30 ml per hour and was in a negative balance a 300
ml Ringers lactate bolus was administered. If the patient
had positive fluid balance a low dose dopamine infusion
was started [9].
Ethical considerations
The Ethics Committee of the Faculty of Health Sciences
gave approval for the initial study and the programme
remains registered with the Ethics Committee. The hospi-
tal administration at each hospital continues to give
approval for the audit. Patient information is anonymised
once entered into the database.
Results
In 1997/1998 there were 27,025 births in the Pretoria
Academic Complex and 32,814 births in 2002/2003, an
increase of 21.4%. This excludes all referrals and patients
born in private institutions. The Maternal Mortality Ratio
(MMR) for indigent patients from the Pretoria area, dying
from complications of hypertension in pregnancy
remained unchanged with 9 deaths in 1997/1998 (MMR
33.3/100000 births) and 8 deaths in 2002/2003 (MMR
24.4/100000 births). However the prevalence of women
severely ill from complications of hypertension in preg-
nancy in our population rose from 40 patients (0.15%) in
1997/1998 to 64 patients (0.20%) in 2002/2003. The
denominators for referred patients are unknown.
Auditing all patients with complicated hypertension dem-
onstrated that in 1997/1998 there were 79 SAMM and a
further 18 maternal deaths compared to 91 women with
SAMM and 13 maternal deaths in 2002/2003. The distri-
bution of age and parity in both groups was similar: age
less than 20 years (11% and 9.6%), 20 to 29 years (50.6%
and 52.8%), 30 to 39 years (28.9% and 31.7%) and prim-
igravid (42.3% and 43.2%).
Table 4 compares the distribution of the different catego-
ries of women with severe complications of hypertension
in pregnancy. Statistically significantly more women had
severe complications following eclampsia during 1997/
1998 compared to 2002/2003, but the opposite was true
for women with severe complications following HELLP
syndrome. It is important to note that the diagnosis of
eclampsia or HELLP syndrome does not automatically
classify a woman as having severe morbidity as there also
has to be organ system dysfunction as defined above.
Overall, the Mortality Index declined from 18.6% in
1997/1998 to 12.5% in 2002/2003 (Odds Ratio 0.62,
95% CI 0.27–1.45). There were no differences in Mortal-
ity Indices within the individual disease categories.
Table 5 compares the organ system dysfunction/failure for
severely ill pregnant women with complications of hyper-
tension. Significantly fewer women had renal failure
(34.0% vs 12.5%, RR 0.37, 95% CI 0.21 – 0.66) and cere-
bral complications (35.1% vs 14.4%, RR 0.52 95%CI 0.34
– 0.81) than before, and liver dysfunction (7.2% vs 1.9%,
RR 0.27 95%CI 0.06 – 1.25) tended to be lower. However,
there was a trend towards an increase in number of
women who had immune system failure (2.0% to 8.7%,
RR 4.2 95%CI 0.93 – 18.94) and respiratory failure
(21.6% to 30.8%, RR 1.42 95%CI 0.88 – 2.29) in the sec-Reproductive Health 2005, 2:7 http://www.reproductive-health-journal.com/content/2/1/7
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ond period compared to the first although it did not reach
significance. Cardiac failure remained constant (30.9%
and 26.0% RR 0.84 95%CI 0.54 – 1.30).
The average number of organ systems that failed or were
dysfunctional for all critically ill women were 1.69 in
1997/1998 and 1.25 in 2002/2003. This indicates that per
critically patient there were less severely compromised
organ systems in the second period compared to the first.
Table 6 examines the patients that came from the Pretoria
area only. The pattern of organ system dysfunction/failure
was the same but the numbers were too small to have suf-
ficient power to detect significant differences. The Mortal-
ity Index in Pretoria for 1997/1998 was 22.5% and 12.5%
for 2002/2003 (OR 0.49, 95% CI 0.15–1.57).
Discussion
This report of managing critically ill pregnant women
with complications of hypertension in pregnancy during
two time periods five years apart has shown a change in
pattern of organ system dysfunction/failure. Fewer
women developed renal failure and cerebral complica-
tions during the later time period. However, other com-
mon complications of the respiratory, cardiovascular and
immune systems did not seem to be affected by the imple-
mentation of the strict protocol.
The possible explanations for the change are better identi-
fication of patients with complications and better man-
agement, and fewer referrals of critically ill patients from
outside areas. By increasing the number of cases identified
with improved surveillance, one would have expected a
sudden increase in the rate of critically ill women being
treated followed by a levelling off. However, there has
been a steady increase in the rate from 84/100000 births
in 1999, 108/100000 births in 2000 and 138/100000
births in 2001 [14].
Table 4: Comparison between the sub-categories of complications of hypertension in pregnancy and their Mortality Indices.
1997–1998 2002–2003 p MI
MD SAMM Total % MI MD SAMM Total % MI
Chronic Hypertension 1 2 3 3.1 33.3 1 4 5 4.8 20.0
Proteinuric Hypertension 6 22 28 28.9 21.4 4 30 34 32.7 11.8 0.49
Eclampsia* 9 38 47 48.5 19.1 6 22 28 26.9 21.4 0.52
HELLP** 2 17 19 19.6 10.5 1 35 36 34.6 2.8 0.27
Liver rupture 0 0 0 0.0 0.0 1 0 1 1.0 100.0
All Hypertension 18 79 97 100 18.5 13 91 104 100 12.5 0.32
MD – Maternal Death; SAMM – Severe acute maternal morbidity; MI – Mortality Index
* – Significant decline in proportion of eclampsia from 1997/8 to 2002/3, p = 0.0026
** – Significant increase in proportion of women with HELLP syndrome 1997/8 to 2002/3, p = 0.026
Table 5: Comparison of the prevalence of organ system dysfunction/failure per severely ill pregnant women with complications due to 
hypertension.
Organ system 1997–1998 2002–2003 RR (95% CI)
SAMM 
n = 79
MD 
n = 18
SAMM+M
D N = 97
% OSD SAMM 
N = 91
MD 
N = 13
SAMM+M
D N = 104
% OSD
Hypovolaemic shock 7 1 8 8.2 5 1 6 5.8 0.7 (0.25 – 1.94)
Respiratory failure 17 4 21 21.6 29 3 32 30.8 1.42 (0.88 – 2.29)
Cardiac failure 25 5 30 30.9 23 4 27 26.0 0.84 (0.54 – 1.30)
Renal failure 29 4 33 34.2 11 2 13 12.5 0.37 (0.21 – 0.66)
Liver failure 5 2 7 7.2 1 1 2 1.9 0.27 (0.06 – 1.25)
Cerebral complications 24 10 34 35.1 9 6 15 14.4 0.52 (0.34 – 0.81)
Haematological dysfunction 25 4 29 29.9 26 1 27 26.0 0.87 (0.56 – 1.36)
Immune system failure* 1 1 2 2.1 6 3 9 8.7 4.2 (0.93 – 18.94)
% OSD – Percentage of severely ill women who developed that organ system dysfunction/failure
Note: A patient can have more than one organ system dysfunction/failure
* Fisher exact: 2 sided 0.060
: 1 sided 0.038Reproductive Health 2005, 2:7 http://www.reproductive-health-journal.com/content/2/1/7
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The reduction in critically ill patients referred from out-
side the Pretoria area could also account for the change in
our findings. The longer time to get into a tertiary unit is
likely to increase the severity of the complications. Thus
the shift from 61% of critically ill women being referred
in 1997/1998 as opposed to only 48% in 2002/2003
could account for the change. Examining only the cases
from the Pretoria area (Table 6), the same shift in pattern
is seen although the number of cases was too few to detect
significant changes.
The final explanation is that the management of the
patients has improved. This is supported by the decreased
number of dysfunctional organ systems per patient; it fell
from 1.69 in 1997/1998 to 1.25 in 2002/2003. This
change may be associated with the introduction and
adherence to a strict protocol for managing such critically
ill women. It is postulated that using the strict protocol
may have prevented further organ systems from becoming
involved. The strict protocol was based on the audit in
1997/1998 and the introduction of treatment research
findings such as the use of magnesium sulphate for
women with severe pre-eclampsia [8]. The feedback sys-
tem of regular audit meetings to discuss cases, one by one
meetings and regular teaching sessions to discuss specific
issues confirms the success found in previous randomised
trials [6]. The rapid turnover of staff necessitates regular
reinforcement of protocols.
One of the limitations of our study was that we used a
'before and after' design to evaluate the effect of the imple-
mentation of a strict protocol with no control patients in
any of the time periods. Further, the study could not
explain the fact that there was no reduction in cardiac and
respiratory problems.
The lack of change in the respiratory and cardiovascular
system organ dysfunction/failure suggests that there is still
significant room for improving the protocol. The confi-
dential enquiries into maternal deaths in the UK revealed
that 37% of maternal deaths due to eclampsia or pre-
eclampsia during the 1985–1999 period are being
ascribed to "pulmonary" [15]. Adult respiratory distress
syndrome has been described as contributing factor in
28% [16] of deaths associated with HELLP syndrome.
Cardiac and respiratory functions in severe pre-eclampsia
are not well understood and future research must attempt
to identify the changes that can improve the outcome. The
increasing incidence of HIV infection in the area accounts
for the rise in immune system failure. This may also affect
pulmonary and cardiac function.
The 33% increase of women who were critically ill due to
complications of hypertension from the Pretoria area is
disturbing. The reason for this is unknown. There has
been a steady influx of people into the Gauteng area dur-
ing the last 5 years. This is confirmed by the 2001 Census
[17] and the increase of more than twenty percent of
births in the Pretoria area. This influx of many impover-
ished people looking for employment would be expected
to bring more unhealthy people to the region. This will
lead to increased pressure on the primary health care serv-
ices to identify these patients early (at antenatal clinics)
and refer appropriately, and increase the pressure on sec-
ondary and tertiary services that must deal with the
increased load of critically ill patients. Appropriate plans
for distribution of resources need to be made to deal with
this challenge.
Conclusion
The strict protocol approach based on the systemic evalu-
ation of critically ill pregnant women due to complica-
tions of hypertension has been associated with a
Table 6: Comparison of the prevalence of organ system dysfunction/failure per severely ill pregnant women with complications due to 
hypertension for patients only from the Pretoria area.
Organ system 1997–1998 2002–2003
SAMM 
n = 31
MD 
n = 9
SAMM+MD 
N = 40
% OSD SAMM 
N = 56
MD 
N = 8
SAMM+MD 
N = 64
% OSD
Hypovolaemic shock 2 0 2 5.0 3 1 4 6.3
Respiratory failure 7 3 10 25.0 16 2 18 28.1
Cardiac failure 12 4 16 40.0 13 3 16 25.0
Renal failure 6 1 7 17.5 5 1 6 9.4
Liver failure 0 0 0 0.0 1 1 2 3.1
Cerebral complications 8 4 12 30.0 4 3 7 10.9
Haematological dysfunction 9 1 10 25.0 19 1 20 31.3
Immune system failure 0 1 0 2.5 2 2 4 6.3
% OSD – Percentage of severely ill women who developed that organ system dysfunction/failure
Note: A patient can have more than one organ system dysfunction/failurePublish with BioMed Central    and   every 
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reduction in the preventable complications, such as renal
failure and cerebral compromise by improved fluid man-
agement and blood pressure control. However, there has
been no change in the prevalence of cardiac or respiratory
failure. Cardiac and respiratory function in women with
severe hypertension in pregnancy needs further investiga-
tion and strategies need to be developed to improve its
management.
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